These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35405115)

  • 81. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties.
    Uberti MA; Hall RA; Minneman KP
    Mol Pharmacol; 2003 Dec; 64(6):1379-90. PubMed ID: 14645668
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Different roles of alpha1-adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats.
    Zhang Y; Yan J; Chen K; Song Y; Lu Z; Chen M; Han C; Zhang Y
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):626-33. PubMed ID: 15479171
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Advantageous safety profile of a dual selective alpha(2C) agonist/alpha(2A) antagonist antinociceptive agent.
    Delaunois A; De Ron P; Dedoncker P; Rosseels ML; Cornet M; Jnoff E; Hanon E; Guyaux M; Depelchin BO
    Fundam Clin Pharmacol; 2014 Aug; 28(4):423-38. PubMed ID: 24020399
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.
    Nakamura S; Taniguchi T; Suzuki F; Akagi Y; Muramatsu I
    Br J Pharmacol; 1999 Jul; 127(6):1367-74. PubMed ID: 10455286
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist.
    Heusler P; Rauly-Lestienne I; Tourette A; Tardif S; Ailhaud MC; Croville G; Cussac D
    Eur J Pharmacol; 2010 Aug; 640(1-3):8-14. PubMed ID: 20450907
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.
    Paris A; Philipp M; Tonner PH; Steinfath M; Lohse M; Scholz J; Hein L
    Anesthesiology; 2003 Oct; 99(4):889-95. PubMed ID: 14508322
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors.
    Eltze M; Boer R; Michel MC; Hein P; Testa R; Ulrich WR; Kolassa N; Sanders KH
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):649-62. PubMed ID: 11414660
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Specific role of α2A - and α2B -, but not α2C -, adrenoceptor subtypes in the inhibition of the vasopressor sympathetic out-flow in diabetic pithed rats.
    Altamirano-Espinoza AH; Manrique-Maldonado G; Marichal-Cancino BA; Villalón CM
    Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):31-8. PubMed ID: 25407049
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
    Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
    Docherty JR
    Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):49-57. PubMed ID: 24074250
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
    Takei R; Ikegaki I; Shibata K; Tsujimoto G; Asano T
    Jpn J Pharmacol; 1999 Apr; 79(4):447-54. PubMed ID: 10361884
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Agonist-specific coupling of a cloned human alpha1A-adrenoceptor to different second messenger pathways.
    Richardson J; Chatwin H; Hirasawa A; Tsujimoto G; Evans PD
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):333-41. PubMed ID: 12690424
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility.
    Zádori ZS; Fehér Á; Tóth VE; Al-Khrasani M; Köles L; Sipos S; Del Bello F; Pigini M; Gyires K
    Dig Dis Sci; 2016 Jun; 61(6):1512-23. PubMed ID: 26860509
    [TBL] [Abstract][Full Text] [Related]  

  • 94. α
    Davis BJ; Chapple CR; Sellers DJ; Naylor AL; Sillar D; Campbell A; Chess-Williams R
    J Pharmacol Sci; 2018 Aug; 137(4):366-371. PubMed ID: 30139713
    [TBL] [Abstract][Full Text] [Related]  

  • 95. alpha1A-adrenoceptors activate glucose uptake in L6 muscle cells through a phospholipase C-, phosphatidylinositol-3 kinase-, and atypical protein kinase C-dependent pathway.
    Hutchinson DS; Bengtsson T
    Endocrinology; 2005 Feb; 146(2):901-12. PubMed ID: 15550506
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacological properties of A-204176, a novel and selective alpha1A adrenergic agonist, in in vitro and in vivo models of urethral function.
    O'Neill AB; Buckner SA; Brune ME; Milicic I; Daza AV; Gauvin DM; Altenbach RJ; Meyer MD; Williams M; Sullivan JP; Brioni JD
    Life Sci; 2001 Nov; 70(2):181-97. PubMed ID: 11787943
    [TBL] [Abstract][Full Text] [Related]  

  • 97. In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha1A-adrenoceptor antagonist.
    Chang RS; Chen TB; O'Malley SS; Pettibone DJ; DiSalvo J; Francis B; Bock MG; Freidinger R; Nagarathnam D; Miao SW; Shen Q; Lagu B; Murali Dhar TG; Tyagarajan S; Marzabadi MR; Wong WC; Gluchowski C; Forray C
    Eur J Pharmacol; 2000 Dec; 409(3):301-12. PubMed ID: 11108825
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Interaction between alpha(1)- and alpha(2)-adrenoreceptors contributes to enhanced constrictor effects of norepinephrine in mesenteric veins compared to arteries.
    Sporkova A; Perez-Rivera A; Galligan JJ
    Eur J Pharmacol; 2010 Sep; 643(2-3):239-46. PubMed ID: 20599923
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Designing Chromane Derivatives as α
    Lv X; Zhou P; Qiao X; Li Y; Yang X; Wang J; He X; Su R
    J Med Chem; 2024 Jul; 67(13):11435-11449. PubMed ID: 38889119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.